Prostate cancer-specific enrichment of TP53 missense mutations elicits differential, context-dependent biochemical and biologic outcomes

被引：0
|
作者：
McCann, Jennifer J. [1 ]
Vasilevskaya, Irina [1 ]
PoudelNeupane, Neermala [1 ]
Dean, Jeffry [1 ]
Mandigo, Amy [1 ]
De Leeuw, Renee [1 ]
McNair, Chris [1 ]
Schiewer, Matthew [1 ]
Knudsen, Karen [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4511
引用
收藏
页数：2
相关论文
共 10 条
  • [1] Specific missense mutations in TP53 elicit contrasting biochemical and biological outcomes affecting prostate cancer progression
    McCann, Jennifer J.
    Dean, Jeffry L.
    De Leeuw, Renee
    Schiewer, Matthew J.
    McNair, Christopher M.
    Knudsen, Karen E.
    CANCER RESEARCH, 2017, 77
  • [2] TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance
    Tefferi, Ayalew
    Abdelmagid, Maymona
    Loscocco, Giuseppe G.
    Fathima, Saubia
    Begna, Kebede H.
    Al-Kali, Aref
    Foran, James
    Palmer, Jeanne
    Badar, Talha
    Patnaik, Mrinal M.
    Reichard, Kaaren K.
    He, Rong
    Mendoza, Cinthya J. Zepeda
    Shah, Mithun
    Orazi, Attilio
    Arber, Daniel A.
    Pardanani, Animesh
    Vannucchi, Alessandro M.
    Hiwase, Devendra
    Gangat, Naseema
    Guglielmelli, Paola
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (04) : 552 - 560
  • [3] ignificance of distinct specifically enriched missense TP53 mutations in prostate cancer
    Vasilevskaya, Irina
    McCann, Jennifer
    McNair, Christopher
    Neupane, Neermala Poudel
    Gallagher, Peter
    Knudsen, Karen E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] TP53 hotspot mutations as immunoreactive neoantigens define a signature with differential survival outcomes in advanced ovarian cancer
    Garziera, M.
    Cecchin, E.
    Polesel, J.
    Canzonieri, V.
    Sorio, R.
    Gagno, S.
    Scalone, S.
    Roncato, R.
    De Mattia, E.
    Poletto, E.
    Giorda, G.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
    Pallocca, Matteo
    Goeman, Frauke
    De Nicola, Francesca
    Melucci, Elisa
    Sperati, Francesca
    Terrenato, Irene
    Pizzuti, Laura
    Casini, Beatrice
    Gallo, Enzo
    Amoreo, Carla Azzurra
    Vici, Patrizia
    Di Lauro, Luigi
    Buglioni, Simonetta
    Diodoro, Maria Grazia
    Pescarmona, Edoardo
    Mazzotta, Marco
    Barba, Maddalena
    Fanciulli, Maurizio
    De Maria, Ruggero
    Ciliberto, Gennaro
    Maugeri-Sacca, Marcello
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [6] Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
    Matteo Pallocca
    Frauke Goeman
    Francesca De Nicola
    Elisa Melucci
    Francesca Sperati
    Irene Terrenato
    Laura Pizzuti
    Beatrice Casini
    Enzo Gallo
    Carla Azzurra Amoreo
    Patrizia Vici
    Luigi Di Lauro
    Simonetta Buglioni
    Maria Grazia Diodoro
    Edoardo Pescarmona
    Marco Mazzotta
    Maddalena Barba
    Maurizio Fanciulli
    Ruggero De Maria
    Gennaro Ciliberto
    Marcello Maugeri-Saccà
    Journal of Translational Medicine, 16
  • [7] TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC)
    Citarella, F.
    Russano, M.
    Fiorenti, M.
    La Cava, G.
    Pizzutilo, E. G.
    Martinelli, F.
    Pierri, S.
    Russo, A.
    Muscolino, P.
    Sapuppo, E.
    Marinello, A.
    Aldea, M.
    Besse, B.
    Filetti, M.
    Lombardi, P.
    Vitale, A.
    Buzzacchino, F.
    Cristofani, L.
    Lugini, A.
    Cortellini, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S848 - S848
  • [8] TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas
    Seagle, Brandon-Luke L.
    Yang, Chia-Ping Huang
    Eng, Kevin H.
    Dandapani, Monica
    Odunsi-Akanji, Oluwatosin
    Goldberg, Gary L.
    Odunsi, Kunle
    Horwitz, Susan Band
    Shahabi, Shohreh
    GYNECOLOGIC ONCOLOGY, 2015, 138 (01) : 159 - 164
  • [9] Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
    Miguel Gonzalez Velez
    Heidi E. Kosiorek
    Jan B. Egan
    Andrea L. McNatty
    Irbaz B. Riaz
    Steven R. Hwang
    Glenn A. Stewart
    Thai H. Ho
    Cassandra N. Moore
    Parminder Singh
    Renee K. Sharpsten
    Brian A. Costello
    Alan H. Bryce
    Prostate Cancer and Prostatic Diseases, 2022, 25 : 479 - 483
  • [10] Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
    Velez, Miguel Gonzalez
    Kosiorek, Heidi E.
    Egan, Jan B.
    McNatty, Andrea L.
    Riaz, Irbaz B.
    Hwang, Steven R.
    Stewart, Glenn A.
    Ho, Thai H.
    Moore, Cassandra N.
    Singh, Parminder
    Sharpsten, Renee K.
    Costello, Brian A.
    Bryce, Alan H.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (03) : 479 - 483
1